Logo image of EGLA.MI

EUROGROUP LAMINATIONS SPA (EGLA.MI) Stock Fundamental Analysis

BIT:EGLA - Euronext Milan - IT0005527616 - Common Stock - Currency: EUR

2.54  -0.01 (-0.47%)

Fundamental Rating

5

Overall EGLA gets a fundamental rating of 5 out of 10. We evaluated EGLA against 54 industry peers in the Electrical Equipment industry. While EGLA is still in line with the averages on profitability rating, there are concerns on its financial health. EGLA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

EGLA had positive earnings in the past year.
In the past year EGLA had a positive cash flow from operations.
EGLA had positive earnings in each of the past 5 years.
Of the past 5 years EGLA 4 years had a positive operating cash flow.
EGLA.MI Yearly Net Income VS EBIT VS OCF VS FCFEGLA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

EGLA has a Return On Assets of 2.37%. This is in the better half of the industry: EGLA outperforms 61.11% of its industry peers.
The Return On Equity of EGLA (7.02%) is better than 61.11% of its industry peers.
EGLA has a Return On Invested Capital of 5.77%. This is comparable to the rest of the industry: EGLA outperforms 59.26% of its industry peers.
EGLA had an Average Return On Invested Capital over the past 3 years of 9.24%. This is in line with the industry average of 7.58%.
Industry RankSector Rank
ROA 2.37%
ROE 7.02%
ROIC 5.77%
ROA(3y)3.12%
ROA(5y)2.46%
ROE(3y)13.02%
ROE(5y)11.21%
ROIC(3y)9.24%
ROIC(5y)7.04%
EGLA.MI Yearly ROA, ROE, ROICEGLA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

EGLA's Profit Margin of 3.58% is fine compared to the rest of the industry. EGLA outperforms 64.81% of its industry peers.
EGLA's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 7.27%, EGLA is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
EGLA's Operating Margin has improved in the last couple of years.
EGLA has a Gross Margin of 25.56%. This is in the lower half of the industry: EGLA underperforms 64.81% of its industry peers.
EGLA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.27%
PM (TTM) 3.58%
GM 25.56%
OM growth 3Y7.25%
OM growth 5YN/A
PM growth 3Y2.08%
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5YN/A
EGLA.MI Yearly Profit, Operating, Gross MarginsEGLA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EGLA is creating some value.
EGLA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EGLA has less shares outstanding
Compared to 1 year ago, EGLA has a worse debt to assets ratio.
EGLA.MI Yearly Shares OutstandingEGLA.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EGLA.MI Yearly Total Debt VS Total AssetsEGLA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that EGLA is in the distress zone and has some risk of bankruptcy.
EGLA has a Altman-Z score of 1.47. This is comparable to the rest of the industry: EGLA outperforms 46.30% of its industry peers.
EGLA has a Debt/Equity ratio of 0.61. This is a neutral value indicating EGLA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, EGLA is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACC0.98
WACC5.87%
EGLA.MI Yearly LT Debt VS Equity VS FCFEGLA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.66 indicates that EGLA should not have too much problems paying its short term obligations.
EGLA has a Current ratio of 1.66. This is comparable to the rest of the industry: EGLA outperforms 53.70% of its industry peers.
EGLA has a Quick Ratio of 1.66. This is a bad value and indicates that EGLA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, EGLA is in line with its industry, outperforming 46.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.92
EGLA.MI Yearly Current Assets VS Current LiabilitesEGLA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for EGLA have decreased by -5.02% in the last year.
EGLA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.60% yearly.
EGLA shows a small growth in Revenue. In the last year, the Revenue has grown by 4.00%.
The Revenue has been growing by 16.01% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.02%
EPS 3Y20.6%
EPS 5YN/A
EPS Q2Q%109.13%
Revenue 1Y (TTM)4%
Revenue growth 3Y16.01%
Revenue growth 5YN/A
Sales Q2Q%14.87%

3.2 Future

Based on estimates for the next years, EGLA will show a very strong growth in Earnings Per Share. The EPS will grow by 20.35% on average per year.
Based on estimates for the next years, EGLA will show a quite strong growth in Revenue. The Revenue will grow by 11.55% on average per year.
EPS Next Y-3.61%
EPS Next 2Y17.79%
EPS Next 3Y20.35%
EPS Next 5YN/A
Revenue Next Year9.39%
Revenue Next 2Y11.43%
Revenue Next 3Y11.55%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EGLA.MI Yearly Revenue VS EstimatesEGLA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
EGLA.MI Yearly EPS VS EstimatesEGLA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.26, which indicates a rather cheap valuation of EGLA.
94.44% of the companies in the same industry are more expensive than EGLA, based on the Price/Earnings ratio.
EGLA is valuated cheaply when we compare the Price/Earnings ratio to 26.30, which is the current average of the S&P500 Index.
EGLA is valuated correctly with a Price/Forward Earnings ratio of 13.96.
EGLA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EGLA is cheaper than 68.52% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EGLA to the average of the S&P500 Index (22.06), we can say EGLA is valued slightly cheaper.
Industry RankSector Rank
PE 7.26
Fwd PE 13.96
EGLA.MI Price Earnings VS Forward Price EarningsEGLA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EGLA indicates a rather cheap valuation: EGLA is cheaper than 85.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.55
EGLA.MI Per share dataEGLA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of EGLA may justify a higher PE ratio.
A more expensive valuation may be justified as EGLA's earnings are expected to grow with 20.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.79%
EPS Next 3Y20.35%

More info and screens

4

5. Dividend

5.1 Amount

EGLA has a Yearly Dividend Yield of 1.52%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.25, EGLA pays a better dividend. On top of this EGLA pays more dividend than 83.33% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.38, EGLA is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

EGLA pays out 25.97% of its income as dividend. This is a sustainable payout ratio.
DP25.97%
EPS Next 2Y17.79%
EPS Next 3Y20.35%
EGLA.MI Yearly Income VS Free CF VS DividendEGLA.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 -50M -100M
EGLA.MI Dividend Payout.EGLA.MI Dividend Payout, showing the Payout Ratio.EGLA.MI Dividend Payout.PayoutRetained Earnings

More info and screens

EUROGROUP LAMINATIONS SPA

BIT:EGLA (6/6/2025, 11:59:47 AM)

2.54

-0.01 (-0.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners46.46%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap238.81M
Analysts73.33
Price Target2.88 (13.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0.09
Dividend Growth(5Y)N/A
DP25.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-38.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-42.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.09%
Revenue NY rev (3m)-13.53%
Valuation
Industry RankSector Rank
PE 7.26
Fwd PE 13.96
P/S 0.27
P/FCF N/A
P/OCF 3.94
P/B 0.54
P/tB 0.6
EV/EBITDA 5.55
EPS(TTM)0.35
EY13.78%
EPS(NY)0.18
Fwd EY7.16%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.64
OCFY25.38%
SpS9.25
BVpS4.72
TBVpS4.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.37%
ROE 7.02%
ROCE 7.81%
ROIC 5.77%
ROICexc 6.18%
ROICexgc 6.55%
OM 7.27%
PM (TTM) 3.58%
GM 25.56%
FCFM N/A
ROA(3y)3.12%
ROA(5y)2.46%
ROE(3y)13.02%
ROE(5y)11.21%
ROIC(3y)9.24%
ROIC(5y)7.04%
ROICexc(3y)13.37%
ROICexc(5y)10.47%
ROICexgc(3y)13.84%
ROICexgc(5y)10.78%
ROCE(3y)12.52%
ROCE(5y)9.54%
ROICexcg growth 3Y-7.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.94%
ROICexc growth 5YN/A
OM growth 3Y7.25%
OM growth 5YN/A
PM growth 3Y2.08%
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5YN/A
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA 2.53
Cap/Depr 193.94%
Cap/Sales 9.95%
Interest Coverage 2.59
Cash Conversion 56.23%
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.92
Altman-Z 1.47
F-Score4
WACC5.87%
ROIC/WACC0.98
Cap/Depr(3y)268.07%
Cap/Depr(5y)220.65%
Cap/Sales(3y)10.47%
Cap/Sales(5y)8.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.02%
EPS 3Y20.6%
EPS 5YN/A
EPS Q2Q%109.13%
EPS Next Y-3.61%
EPS Next 2Y17.79%
EPS Next 3Y20.35%
EPS Next 5YN/A
Revenue 1Y (TTM)4%
Revenue growth 3Y16.01%
Revenue growth 5YN/A
Sales Q2Q%14.87%
Revenue Next Year9.39%
Revenue Next 2Y11.43%
Revenue Next 3Y11.55%
Revenue Next 5YN/A
EBIT growth 1Y-21.34%
EBIT growth 3Y24.41%
EBIT growth 5YN/A
EBIT Next Year65.44%
EBIT Next 3Y30.85%
EBIT Next 5YN/A
FCF growth 1Y46.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.24%
OCF growth 3Y7.77%
OCF growth 5YN/A